Competitive Landscape of the mRNA Vaccines and Therapeutics Market: Leading Companies and Market Share
Market Overview Global mRNA Vaccines and Therapeutics Market size and share is currently valued at USD 54.32 billion in 2024 and is anticipated to generate an estimated revenue of USD 253.83 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 16.7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034 The mRNA vaccines and therapeutics market is characterized by the growing adoption of nucleic acid-based vaccines due to their rapid development timelines, ease of customization, and high efficacy rates. The pandemic underscored the potential of mRNA platforms, leading to global regulatory bodies fast-tracking approvals and investment surging in research and development. Unlike traditional vaccines, mRNA vaccines do not use live virus particles, making them safer and quicker to manufacture. The focus has shifted from emergency use to long-term pipeline development, ...